Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-25-077980
Filing Date
2025-04-10
Accepted
2025-04-10 16:17:15
Documents
2

Document Format Files

Seq Description Document Type Size
1 DEFA14A d943352ddefa14a.htm DEFA14A 34951
2 GRAPHIC g943352g69k37.jpg GRAPHIC 5567
  Complete submission text file 0001193125-25-077980.txt   43742
Mailing Address 110 EAST 59TH STREET NEW YORK NY 10022
Business Address 110 EAST 59TH STREET NEW YORK NY 10022 (212) 883-0200
Royalty Pharma plc (Filer) CIK: 0001802768 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-39329 | Film No.: 25828614
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)